Remote Oncology Medical Science Liaison - MRD/ctDNA Expert

Personalis, Inc; Fremont (CA); À distance; USD 140 000 - 190 000; Plein temps

Avantages offerts par ce poste

Medical insurance

Dental insurance

Vision insurance

401(k) match

Employee stock purchase plan

Tuition reimbursement

Paid time off

Commuter benefits

EV charging stations

Onsite gym

Wellness programs

Résumé du poste

Personalis, Inc. is seeking a Medical Science Liaison (MSL) in oncology to act as a field-based scientific expert. The role emphasizes NeXT Personal MRD and extends support across the oncology portfolio.

The MSL will build relationships with clinicians, KOLs, and researchers, and will provide education and training to internal teams and external stakeholders about the clinical value of our ctDNA assays.

Qualifications

• Advanced degree in life sciences; PhD/MD/PharmD strongly preferred.
• Strong oncology genomics knowledge and experience with ctDNA or MRD.
• 1+ year experience in oncology or precision medicine; MSL experience a plus.
• Excellent communication and relationships with healthcare professionals.
• Willingness to travel up to 50% for field activities.

Responsabilités

• Deliver clinical and scientific presentations on oncology data, especially NeXT Personal MRD.
• Engage KOLs and physicians to promote understanding of ctDNA technologies.
• Represent Personalis at conferences and educational events.
• Travel approximately 50% to field meetings, conferences, and trainings.
• Support clinical research and investigator-initiated trials.
• Contribute to medical content development and education.

Connaissances

MSL experience

Oncology knowledge

Scientific communication

Stakeholder engagement

Formation

PhD/MD/PharmD

MS in life sciences/genetics

Description du poste

Personalis, Inc. is seeking a Medical Science Liaison (MSL) in oncology to act as a field-based scientific expert. The role emphasizes NeXT Personal MRD and extends support across the oncology portfolio.

The MSL will build relationships with clinicians, KOLs, and researchers, and will provide education and training to internal teams and external stakeholders about the clinical value of our ctDNA assays.